Research exam

Question 1: Ascophyllum nodosum and Fucus vesiculosus Extracts Study – Model Answers (40 marks total)

(a) Corresponding author(s) and their affiliations (2 marks)

Answer:

  • The corresponding author is Yu-Tang Tung (typically listed first) from the Graduate Institute of Biotechnology, National Chung Hsing University, Taichung, Taiwan. Other authors are affiliated with Taipei Medical University and its associated institutions.
    (Precise mark worth depends if multiple correspondents; full citation should reflect affiliations.)

(b) Intervention and disease process (2 marks)

Answer:

  • Intervention: Phlorotannin-rich extracts derived from the brown seaweeds Ascophyllum nodosum and Fucus vesiculosus.

  • Disease model: High-energy diet (HED)-induced hyperlipidemia in rats, modeling metabolic syndrome and hyperlipidemia.

(c) Abbreviations (4 marks)

  • WAT – White Adipose Tissue

  • GAE – Gallic Acid Equivalent (commonly used metric for polyphenol content)

  • NIH – Not specified in the abstract; possibly National Institutes of Health or a similar standard—may not apply to this paper. If GAE is the only standard, or if they used NIH units elsewhere in full text, you’d identify it accordingly.

  • p – p-value (probability for statistical significance)

(GAE and p are clear. NIH may need confirmation; if not present in paper, you might indicate “Not applicable” and explain.)

(d) Experimental design details (4 marks)

  • i) Rats per group: 10 rats per group (n = 10), as stated for mean ± SD in figures.

  • ii) Low dose concentration: LCE is low dosage of crude extract—specific concentration not in abstract; assume low dose but exact mg/kg need full text.

  • iii) Medium dose concentration: Similarly, MCE (medium dose).

  • iv) High dose concentration: HCE (high dose).

(Without full text, we note the dosing groups but exact dose values would come from the methods.)

(e) Table 1 Dose-response evaluation (8 marks)**

Without seeing the actual table, but typical interpretation:

  • State whether the data show dose-dependent changes (e.g., incremental changes across LCE → MCE → HCE).

  • Validity depends on statistical significance between groups and linear trend across doses.
    (Would need table to fully assess.)

(f) Figures 4 & 5 effects on WAT (8 marks)**

From abstract:

  • Figure 5: Histopathology showed phlorotannin extract reduced adipocyte size in epididymal WAT.

  • Figure 4: Likely increased lipase activity and improved mitochondrial function, indicating altered WAT metabolism.

(g) Authors’ conclusions and justification (6 marks)**

Answer:

  • Conclusion: Phlorotannin-rich extracts from A. nodosum and F. vesiculosus improved lipid metabolism, reduced hyperlipidemia and inflammation, increased fat tissue lipase activity, and improved antioxidant status—suggesting antihyperlipidemic potential for functional foods or pharmaceuticals.

  • Justification: The data support the conclusions—significant changes in FBS, TC, TG, HDL-C, inflammatory markers (IL-6, TNF-α), antioxidant enzymes (SOD, GPx). However, limitations include lack of human data and dosing clarity.

(h) Contribution to human nutrition knowledge (6 marks)**

Answer:

  • This study is (ii) a significant contribution.

    • It provides novel preclinical evidence on seaweed extracts’ metabolic benefits.

    • Supports their potential in mitigating hyperlipidemia.

    • Further research needed—clinical trials, mechanisms, safety.